|
|
|
|
| LEADER |
01774nam a2200289 u 4500 |
| 001 |
EB001897149 |
| 003 |
EBX01000000000000001060154 |
| 005 |
00000000000000.0 |
| 007 |
tu||||||||||||||||||||| |
| 008 |
200523 r ||| eng |
| 100 |
1 |
|
|a Wells, Charlotte
|
| 245 |
0 |
0 |
|a Injectable botulinum toxin for pelvic pain
|h Elektronische Ressource
|b a review of clinical effectiveness, cost-effectiveness, and guidelines
|c Charlotte Wells, Kelly Farrah
|
| 260 |
|
|
|a Ottawa
|b Canadian Agency for Drugs and Technologies in Health
|c August 22, 2019, 2019
|
| 300 |
|
|
|a 1 PDF file (30 pages)
|b illustration
|
| 653 |
|
|
|a Cost-Benefit Analysis
|
| 653 |
|
|
|a Genital Diseases, Female / drug therapy
|
| 653 |
|
|
|a Pain / drug therapy
|
| 653 |
|
|
|a Treatment Outcome
|
| 653 |
|
|
|a Pelvic Floor Disorders / drug therapy
|
| 653 |
|
|
|a Botulinum Toxins / therapeutic use
|
| 700 |
1 |
|
|a Farrah, Kelly
|e [author]
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b NCBI
|a National Center for Biotechnology Information
|
| 490 |
0 |
|
|a CADTH rapid response report: summary with critical appraisal
|
| 856 |
4 |
0 |
|u https://www.ncbi.nlm.nih.gov/books/NBK549463
|3 Volltext
|n NLM Bookshelf Books
|3 Volltext
|
| 082 |
0 |
|
|a 610
|
| 520 |
|
|
|a There is uncertainty regarding the of effectiveness of botulinum toxin for some chronic pelvic pain conditions. The purpose of this report is to evaluate the evidence regarding the clinical effectiveness and safety of botulinum toxin compared with other treatments or placebo for patients with chronic pelvic floor dysfunction and pain. Evidence regarding the cost-effectiveness of botulinum toxin for pelvic pain was also sought to support decision making. Evidence-based recommendations were sought to provide guidance on the use of botulinum toxin for these conditions
|